Annual report [Section 13 and 15(d), not S-K Item 405]

Schedule of Stock Option Activity (Details)

v3.26.1
Schedule of Stock Option Activity (Details) - USD ($)
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Share-Based Payment Arrangement [Abstract]    
Shares outstanding, beginning balance 276,824  
Weighted average grant price, outstanding beginning balance $ 7.18  
Weighted average remaining contractual period, outstanding 4 years 4 months 20 days 5 years 5 months 26 days
Aggregate intrinsic value outstanding, beginning balance  
Shares, granted
Weighted average grant price, granted  
Aggregate intrinsic value, granted  
Shares, forfeited or expired (30,600)  
Weighted average grant price, forfeited or expired $ 6.27  
Aggregate intrinsic value, forfeited or expired  
Shares outstanding, ending balance 246,224 276,824
Weighted average grant price, outstanding ending balance $ 7.30 $ 7.18
Aggregate intrinsic value outstanding, ending balance  
Shares exercisable, ending balance 246,224  
Weighted average grant price, exercisable ending balance $ 7.30  
Weighted average remaining contractual period, exercisable 4 years 4 months 20 days  
Aggregate intrinsic value, exercisable ending balance  
Shares, vested and expected to vest 246,224  
Weighted average grant price, vested and expected to vest $ 7.30  
Weighted average remaining contractual period, vested and expected to vest 4 years 4 months 20 days  
Aggregate intrinsic value, vested and expected to vest